Dose-dependent effects of ladostigil on microglial activation and cognition in aged rats

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 1, 2013, Pages 345-355

  Weinstock, Marta ^a   Bejar, Corina ^a   Schorer Apelbaum, Donna ^a   Panarsky, Rony ^a   Luques, Lisandro ^a   Shoham, Shai ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Aged rats; Cholinesterase inhibition; Microglial activation; Monoamine oxidase inhibition; Morris water maze; Novel object recognition

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CD11B ANTIGEN; CHOLINESTERASE; LADOSTIGIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BRAIN FORNIX; CELL ACTIVATION; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; MALE; MAZE TEST; MICROGLIA; NONHUMAN; PARIETAL CORTEX; PRIORITY JOURNAL; RAT; REFERENCE MEMORY;

AGING; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD3; BRAIN; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INDANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MACROPHAGE ACTIVATION; MALE; MAZE LEARNING; MEMORY, LONG-TERM; MICROGLIA; MONOAMINE OXIDASE; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); SPLEEN; TH1 CELLS;

EID: 84874661247     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9433-0     Document Type: Article

References (69)

1. Aggleton JP, Albasser MM, Aggleton DJ, Poirier GL, Pearce JM (2010) Lesions of the rat perirhinal cortex spare the acquisition of a complex configural visual discrimination yet impair object recognition. Behav Neurosci 124(1):55-68. doi: 10.1037/a0018320
2. Arivazhagan P, Ayusawa D, Panneerselvam C (2006) Protective efficacy of alpha-lipoic acid on acetylcholinesterase activity in aged rat brain regions. Rejuvenation Res 9(2):198-201. doi: 10.1089/rej.2006.9.198
3. Bar-Am O, Weinreb O, Amit T, Youdim MB (2009) The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats. J Mol Neurosci 37(2):135-145. doi: 10.1007/s12031-008-9139-6
4. Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL (2000) Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99:17-23
5. Baxter MG (2010) "I've seen it all before": explaining age-related impairments in object recognition. Theoretical comment on Burke et al. (2010). Behav Neurosci 124(5):706-709. doi: 10.1037/a0021029
6. Braida D, Paladini E, Griffini P, Lamperti M, Maggi A, Sala M (1996) An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Eur J Pharmacol 302(1-3):13-20
7. Braida D, Ottonello F, Sala M (2000) Eptastigmine improves eight-arm radial maze performance in aged rats. Pharmacol Res 42(4):299-304. doi: 10.1006/phrs.2000.0706
8. Brain P, Benton D (1979) The interpretation of physiological correlates of differential housing in laboratory rats. Life Sci 24:99-115
9. Broadbent NJ, Gaskin S, Squire LR, Clark RE (2010) Object recognition memory and the rodent hippocampus. Learn Mem 17:5-11
10. Bullock R, Dengiz A (2005) Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years. Int J Clin Pract 59:817-822
11. Burke SN, Wallace JL, Hartzell AL, Nematollahi S, Plange K, Barnes CA (2011) Age-associated deficits in pattern separation functions of the perirhinal cortex: a cross-species consensus. Behav Neurosci 125(6):836-847. doi: 10.1037/a0026238
12. Butterfield DA, Reed TT, Perluigi M, De Marco C, Coccia R, Keller JN, Markesbery WR, Sultana R (2007) Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res 1148:243-248. doi: 10.1016/j.brainres.2007.02.084
13. Chang JY, Liu LZ (2000) Catecholamines inhibit microglial nitric oxide production. Brain Res Bull 52(6):525-530
14. Collie A, Maruff P (2000) The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev 24(3):365-374
15. David R, Koulibaly M, Benoit M, Garcia R, Caci H, Darcourt J, Robert P (2008) Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. Clin Neurol Neurosurg 110(1):19-24. doi: 10.1016/j.clineuro.2007.08.007
16. Dunn N, Mullee M, Perry VH, Holmes C (2005) Association between dementia and infectious disease: evidence from a case-control study. Alzheimer disease and associated disorders 19:91-94
17. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
18. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61(5):668-672. doi: 10.1001/archneur.61.5.668
19. Ennaceur A (2010) One-trial object recognition in rats and mice: methodological and theoretical issues. Behav Brain Res 215:244-254
20. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31(1):47-59
21. Ennaceur A, Michalikova S, Bradford A, Ahmed S (2005) Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks. Behav Brain Res 159(2):247-266. doi: 10.1016/j.bbr.2004. 11.006
22. Farlow M, Anand R, Messina J Jr, Hartman R, Veach J (2000) A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. Eur Neurol 44(4):236-241
23. Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H, Sohal RS (1996) Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci U S A 93(10):4765-4769
24. Groner E, Ashani Y, Schorer-Apelbaum D, Sterling J, Herzig Y, Weinstock M (2007) The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates. Mol Pharmacol 71(6):1610-1617. doi: 10.1124/mol.107.033928
25. Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P (2010) Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J Alzheimers Dis 20(Suppl 2):S453-S473. doi: 10.3233/JAD-2010-100321
26. Hut RA, Van der Zee EA (2011) The cholinergic system, circadian rhythmicity, and time memory. Behav Brain Res 221(2):466-480. doi: 10.1016/j.bbr.2010.11.039
27. Hwang J, Hwang H, Lee HW, Suk K (2010) Microglia signaling as a target of donepezil. Neuropharmacology 58(7):1122-1129. doi: 10.1016/j.neuropharm.2010. 02.003
28. Kaasinen V, Nagren K, Jarvenpaa T, Roivainen A, Yu M, Oikonen V, Kurki T, Rinne JO (2002) Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. J Clin Psychopharmacol 22(6):615-620
29. Kim JD, McCarter RJ, Yu BP (1996) Influence of age, exercise, and dietary restriction on oxidative stress in rats. Aging (Milano) 8(2):123-129
30. Lamirault L, Guillou C, Thal C, Simon H (2003) (-)-9- Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old rats. Neurobiol Learn Mem 80(2):113-122
31. Lassmann H (2011) Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease. J Neural Transm 118(5):747-752. doi: 10.1007/s00702-011-0607-8
32. Maccioni RB, Rojo LE, Fernandez JA, Kuljis RO (2009) The role of neuroimmuno- modulation in Alzheimer's disease. Ann N Y Acad Sci 1153:240-246. doi: 10.1111/j.1749-6632.2008.03972.x
33. Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P (2009) Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 8(4):285-305. doi: 10.1016/j.arr.2009.04.002
34. Maruyama W, Weinstock M, Youdim MB, Nagai M, Naoi M (2003) Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]- ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor. Neurosci Lett 341(3):233-236
35. Mori K, Ozaki E, Zhang B, Yang L, Yokoyama A, Takeda I, Maeda N, Sakanaka M, Tanaka J (2002) Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors. Neuropharmacology 43(6):1026-1034
36. Mrak RE, Griffin WS (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26(3):349-354. doi: 10.1016/j.neurobiolaging. 2004.05.010
37. Neumann H, Boucraut J, Hahnel C, Misgeld T, Wekerle H (1996) Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur J Neurosci 8(12):2582-2590
38. Nicolle MM, Gonzalez J, Sugaya K, Baskerville KA, Bryan D, Lund K, Gallagher M, McKinney M (2001) Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents. Neuroscience 107(3):415-431
39. Nitz D (2009) Parietal cortex, navigation, and the construction of arbitrary reference frames for spatial information. Neurobiol Learn Mem 91(2):179-185. doi: 10.1016/j.nlm.2008.08.007
40. Nyska A, Leininger JR, Maronpot RR, Haseman JK, Hailey JR (1998) Effect of individual versus group caging on the incidence of pituitary and Leydig cell tumors in F344 rats: proposed mechanism. Med Hypotheses 50:525-529
41. Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, Walker Z, Kennedy A, Fox N, Rossor M, Brooks DJ (2009) Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 72(1):56-62. doi: 10.1212/01.wnl.0000338622.27876.0d
42. Panarsky R, Luques L, Weinstock M (2012) Anti-inflammatory effects of ladostigil and its metabolites in aged rat brain and in microglial cells. J Neuroimmune Pharmacol 7(2):488-498. doi: 10.1007/s11481-012-9358-z
43. Park LC, Zhang H, Sheu KF, Calingasan NY, Kristal BS, Lindsay JG, Gibson GE (1999) Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J Neurochem 72(5):1948-1958
44. Pepeu G, Casamenti F, Scali C, Jeglinski W (1992) Aging of brain cholinergic neurons: pharmacological interventions. Clin Neuropharmacol 15(Suppl 1 Pt A):31A-32A
45. Persson CM, Wallin AK, Levander S, Minthon L (2009) Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil. BMC Neurol 9:7. doi: 10.1186/1471-2377-9-7
46. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56(3):303-308
47. Pieta Dias C, Martins de Lima MN, Presti-Torres J, Dornelles A, Garcia VA, Siciliani Scalco F, Rewsaat Guimaraes M, Constantino L, Budni P, Dal-Pizzol F, Schroder N (2007) Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Neuroscience 146(4):1719-1725. doi: 10.1016/j.neuroscience.2007.03.018
48. Raschetti R, Albanese E, Vanacore N, Maggini M (2007) Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med 4(11):e338. doi: 10.1371/journal.pmed.0040338
49. Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21(1):172-188. doi: 10.1021/tx700210j
50. Scali C, Giovannini MG, Bartolini L, Prosperi C, Hinz V, Schmidt B, Pepeu G (1997a) Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. Eur J Pharmacol 325(2-3):173-180
51. Scali C, Giovannini MG, Prosperi C, Bartolini L, Pepeu G (1997b) Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats. Pharmacol Res 36(6):463-469. doi: 10.1006/phrs.1997.0252
52. Schneider LS, Insel PS, Weiner MW (2011) Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol 68(1):58-66. doi: 10.1001/archneurol.2010.343
53. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163-189. doi: 10.1189/jlb.0603252
54. Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M (2007) Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 52(3):836-843. doi: 10.1016/j.neuropharm.2006.10.005
55. Smith MA, Nunomura A, Lee HG, Zhu X, Moreira PI, Avila J, Perry G (2005) Chronological primacy of oxidative stress in Alzheimer disease. Neurobiol Aging 26(5):579-580. doi: 10.1016/j.neurobiolaging.2004.09.021
56. Sterling J, Herzig Y, Goren T, Finkelstein N, Lerner D, Goldenberg W, Miskolczi I, Molnar S, Rantal F, Tamas T, Toth G, Zagyva A, Zekany A, Finberg J, Lavian G, Gross A, Friedman R, Razin M, Huang W, Krais B, Chorev M, Youdim MB, Weinstock M (2002) Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. J Med Chem 45(24):5260-5279
57. Takeda A, Loveman E, Clegg A, Kirby J, Picot J, Payne E, Green C (2006) A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Int J Geriatr Psychiatry 21(1):17-28. doi: 10.1002/gps.1402
58. Valla J, Berndt JD, Gonzalez-Lima F (2001) Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 21(13):4923-4930
59. Venneri A, Gorgoglione G, Toraci C, Nocetti L, Panzetti P, Nichelli P (2011) Combining neuropsychological and structural neuroimaging indicators of conversion to Alzheimer's disease in amnestic mild cognitive impairment. Curr Alzheimer Res 8(7):789-797
60. Wang RH, Bejar C, Weinstock M (2000) Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacology 39(3):497-506
61. Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr Alzheimer Res 5(3):342-345
62. Weinstock M, Bejar C, Wang RH, Poltyrev T, Gross A, Finberg JP, Youdim MB (2000) TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease. J Neural Transm Suppl 60:157-169
63. Weinstock M, Luques L, Poltyrev T, Bejar C, Shoham S (2011) Ladostigil prevents age-related glial activation and spatial memory deficits in rats. Neurobiol Aging 32(6):1069-1078. doi: 10.1016/j.neurobiolaging.2009.06.004
64. Wezenberg E, Verkes RJ, Sabbe BG, Ruigt GS, Hulstijn W (2005) Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. Psychopharmacology (Berl) 181(3):582-594. doi: 10.1007/s00213-005-0083-7
65. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256(3):240-246. doi: 10.1111/j.1365-2796.2004.01380.x
66. Winters BD, Saksida LM, Bussey TJ (2006) Paradoxical facilitation of object recognition memory after infusion of scopolamine into perirhinal cortex: implications for cholinergic system function. J Neurosci 26(37):9520-9529. doi: 10.1523/JNEUROSCI.2319-06.2006
67. Xu J, Rong S, Xie B, Sun Z, Zhang L, Wu H, Yao P, Zhang X, Zhang Y, Liu L (2009) Rejuvenation of antioxidant and cholinergic systems contributes to the effect of procyanidins extracted from the lotus seedpod ameliorating memory impairment in cognitively impaired aged rats. Eur Neuropsychopharmacol 19(12):851-860. doi: 10.1016/j.euroneuro.2009.07.006
68. Yasuno F, Kosaka J, Ota M, Higuchi M, Ito H, Fujimura Y, Nozaki S, Takahashi S, Mizukami K, Asada T, Suhara T (2012) Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [(11)C]DAA1106. Psychiatry Res 203(1):67-74
69. Youdim MB, Weinstock M (2001) Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R) aminoindan-5-YL)-ethyl methyl carbamate]. Cell Mol Neurobiol 21(6):555-573